OAKTREE CAPITAL MANAGEMENT LP - BIOMARIN PHARMACEUTICAL INC ownership

BIOMARIN PHARMACEUTICAL INC's ticker is and the CUSIP is 09061GAH4. A total of 63 filers reported holding BIOMARIN PHARMACEUTICAL INC in Q3 2023. The put-call ratio across all filers is - and the average weighting 0.1%.

Quarter-by-quarter ownership
OAKTREE CAPITAL MANAGEMENT LP ownership history of BIOMARIN PHARMACEUTICAL INC
ValueSharesWeighting
Q2 2023$4,380,248
-35.1%
4,448,000
-32.2%
0.06%
-22.7%
Q1 2023$6,747,850
+157.5%
6,561,000
+166.4%
0.08%
+167.9%
Q4 2022$2,620,139
+55.2%
2,463,000
+44.9%
0.03%
+47.4%
Q3 2022$1,688,000
+0.1%
1,700,0000.0%0.02%
-5.0%
Q2 2022$1,687,000
-51.9%
1,700,000
-51.4%
0.02%
-45.9%
Q1 2022$3,507,000
-18.4%
3,500,000
-14.7%
0.04%
-21.3%
Q4 2021$4,300,000
-0.1%
4,103,000
-2.3%
0.05%
-21.7%
Q3 2021$4,305,000
-51.2%
4,198,000
-50.6%
0.06%
-49.6%
Q2 2021$8,829,000
+1690.9%
8,500,000
+1708.5%
0.12%
+750.0%
Q1 2020$493,000
-86.7%
470,000
-86.6%
0.01%
-80.0%
Q4 2019$3,706,000
+72.1%
3,500,000
+66.7%
0.07%
+70.7%
Q1 2019$2,154,000
-85.4%
2,100,000
-85.8%
0.04%
-69.4%
Q4 2018$14,754,000
-26.8%
14,800,000
-21.5%
0.13%
-50.6%
Q3 2018$20,150,000
-34.8%
18,865,000
-38.1%
0.27%
-37.3%
Q2 2018$30,887,000
+512.6%
30,500,000
+515.8%
0.43%
+476.0%
Q3 2017$5,042,0004,953,0000.08%
Other shareholders
BIOMARIN PHARMACEUTICAL INC shareholders Q3 2023
NameSharesValueWeighting ↓
SHENKMAN CAPITAL MANAGEMENT INC 30,138,000$29,510,0003.72%
PFM Health Sciences, LP 45,910,000$46,002,0001.72%
Cheyne Capital Management (UK) LLP 2,320,000$2,330,0001.47%
ADVENT CAPITAL MANAGEMENT /DE/ 41,077,000$41,277,0000.66%
SSI INVESTMENT MANAGEMENT LLC 9,071,000$9,068,0000.50%
PALISADE CAPITAL MANAGEMENT, LP 14,548,000$14,612,0000.34%
RWC Asset Management LLP 7,500,000$7,552,0000.21%
KBC Group NV 400,000$40,316,0000.15%
PROSPECTOR PARTNERS LLC 1,000,000$1,000,0000.12%
MACKAY SHIELDS LLC 11,822,000$11,816,0000.10%
View complete list of BIOMARIN PHARMACEUTICAL INC shareholders